Ligand validation:4LSQ

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 4LSQ designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4LSQ_NAG_G_503	93%	57%	0.065	0.96	0.58	1.07	-	1	0	0	100%	0.9333
4LSQ_NAG_G_508	75%	71%	0.096	0.928	0.53	0.6	-	-	0	0	100%	0.9333
4LSQ_NAG_G_501	75%	68%	0.097	0.929	0.47	0.77	-	1	0	0	100%	0.9333
4LSQ_NAG_G_505	72%	54%	0.099	0.922	0.48	1.27	-	1	0	0	100%	0.9333
4LSQ_NAG_G_506	60%	63%	0.106	0.89	0.57	0.85	-	1	0	0	100%	0.9333
4LSQ_NAG_G_504	40%	65%	0.143	0.853	0.61	0.72	-	-	1	0	100%	0.9333
4LSQ_NAG_G_507	36%	58%	0.142	0.834	0.42	1.19	-	2	0	0	100%	0.9333
4LSQ_NAG_G_502	29%	55%	0.156	0.813	0.48	1.23	-	3	1	0	100%	0.9333
4LSQ_NAG_G_509	10%	69%	0.197	0.694	0.5	0.68	-	-	0	0	100%	0.9333
4YFL_NAG_E_507	98%	70%	0.061	0.985	0.48	0.66	-	-	0	0	100%	0.9333
3SE8_NAG_G_734	94%	68%	0.063	0.961	0.56	0.68	-	-	0	0	100%	0.9333
7SX7_NAG_A_508	92%	71%	0.073	0.964	0.28	0.84	-	1	0	0	100%	0.9333
4DVW_NAG_A_503	91%	65%	0.087	0.973	0.51	0.81	-	-	1	0	100%	0.9333
4LSR_NAG_G_502	90%	62%	0.08	0.964	0.61	0.85	-	-	0	0	100%	0.9333
3H0C_NAG_A_794	100%	56%	0.021	0.995	0.61	1.08	-	1	0	0	100%	0.9333
5LDS_NAG_B_1007	100%	67%	0.022	0.995	0.48	0.79	-	-	0	0	100%	0.9333
5O5D_NAG_A_601	100%	65%	0.022	0.994	0.32	0.99	-	1	0	0	100%	0.9333
6MUG_NAG_G_629	100%	76%	0.022	0.994	0.35	0.58	-	-	0	0	100%	0.9333
3GXM_NAG_A_498	100%	45%	0.026	0.992	0.75	1.34	-	2	0	0	100%	0.9333

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.